These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8857570)

  • 1. On the metabolism and the toxicological analysis of methylenedioxyphenylalkylamine designer drugs by gas chromatography-mass spectrometry.
    Maurer HH
    Ther Drug Monit; 1996 Aug; 18(4):465-70. PubMed ID: 8857570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicological detection of the designer drug 3,4-methylenedioxyethylamphetamine (MDE, "Eve") and its metabolites in urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay.
    Ensslin HK; Kovar KA; Maurer HH
    J Chromatogr B Biomed Appl; 1996 Aug; 683(2):189-97. PubMed ID: 8891915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the metabolites of the new designer drugs bk-MBDB and bk-MDEA in human urine.
    Zaitsu K; Katagi M; Kamata HT; Kamata T; Shima N; Miki A; Tsuchihashi H; Mori Y
    Forensic Sci Int; 2009 Jul; 188(1-3):131-9. PubMed ID: 19406592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ('Ecstasy').
    Maurer HH; Bickeboeller-Friedrich J; Kraemer T; Peters FT
    Toxicol Lett; 2000 Mar; 112-113():133-42. PubMed ID: 10720722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of some N-hydroxylated metabolites of (+/-)-3,4-methylenedioxymethamphetamine in horse urine by gas chromatography-mass spectrometry.
    Dumasia MC
    Xenobiotica; 2003 Oct; 33(10):1013-25. PubMed ID: 14555338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of racemic 3,4-methylenedioxyethylamphetamine in humans. Isolation, identification, quantification, and synthesis of urinary metabolites.
    Ensslin HK; Maurer HH; Gouzoulis E; Hermle L; Kovar KA
    Drug Metab Dispos; 1996 Aug; 24(8):813-20. PubMed ID: 8869814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical isomer analysis of 3,4-methylene-dioxyamphetamine analogues and their stereoselective disposition in rats.
    Matsushima K; Nagai T; Kamiyama S
    J Anal Toxicol; 1998; 22(1):33-9. PubMed ID: 9491966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry.
    Meyer MR; Wilhelm J; Peters FT; Maurer HH
    Anal Bioanal Chem; 2010 Jun; 397(3):1225-33. PubMed ID: 20333362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of MDMA and its metabolites in urine by GC and GC/MS].
    Shen M; Yan W; Shen B; Xiang P; Huang Z; Liu W; Bo J
    Fa Yi Xue Za Zhi; 1998; 14(1):10-1, 24, 61. PubMed ID: 11360579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous determination of amphetamines and amphetamine-derived designer drugs in human urine by GC-MS.
    Maresová V; Chadt J; Prikryl L
    Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():121-4. PubMed ID: 17159795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New designer drug 2,5-dimethoxy-4-ethylthio-beta-phenethylamine (2C-T-2): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry.
    Theobald DS; Staack RF; Puetz M; Maurer HH
    J Mass Spectrom; 2005 Sep; 40(9):1157-72. PubMed ID: 16041763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vivo and in vitro metabolism and the detectability in urine of 3',4'-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MS(n.).
    Meyer MR; Mauer S; Meyer GM; Dinger J; Klein B; Westphal F; Maurer HH
    Drug Test Anal; 2014; 6(7-8):746-56. PubMed ID: 24124065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDA-MDMA concentrations in urine specimens.
    Kunsman GW; Levine B; Kuhlman JJ; Jones RL; Hughes RO; Fujiyama CI; Smith ML
    J Anal Toxicol; 1996; 20(7):517-21. PubMed ID: 8934299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of a new designer drug, N-hydroxy-3,4-methylenedioxymethamphetamine and its metabolites in rats using ultra-performance liquid chromatography-tandem mass spectrometry.
    Kikura-Hanajiri R; Kawamura M; Miyajima A; Sunouchi M; Goda Y
    Forensic Sci Int; 2010 May; 198(1-3):62-9. PubMed ID: 20299167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites by gas chromatography/mass spectrometry.
    Pizarro N; Llebaria A; Cano S; Joglar J; Farré M; Segura J; de la Torre R
    Rapid Commun Mass Spectrom; 2003; 17(4):330-6. PubMed ID: 12569443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the enantiomers of 3,4-methylenedioxy-N-ethylamphetamine (MDE, "Eve") and its metabolite 3,4-methylenedioxyamphetamine (MDA) in rat brain.
    Hegadoren KM; Baker GB; Coutts RT
    J Pharmacol Toxicol Methods; 1995 Oct; 34(2):117-23. PubMed ID: 8563033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the metabolism and toxicological detection of the designer drug 4-methylthioamphetamine (4-MTA) in human urine using gas chromatography-mass spectrometry.
    Ewald AH; Peters FT; Weise M; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):123-31. PubMed ID: 16027051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and toxicological detection of a new designer drug, N-(1-phenylcyclohexyl)propanamine, in rat urine using gas chromatography-mass spectrometry.
    Sauer C; Peters FT; Staack RF; Fritschi G; Maurer HH
    J Chromatogr A; 2008 Apr; 1186(1-2):380-90. PubMed ID: 18035363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro metabolism of 3,4-(methylenedioxy)methamphetamine in the rat: identification of metabolites using an ion trap detector.
    Lim HK; Foltz RL
    Chem Res Toxicol; 1988; 1(6):370-8. PubMed ID: 2908769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the designer drugs 3, 4-methylenedioxymethamphetamine, 3,4-methylenedioxyethylamphetamine, and 3,4-methylenedioxyamphetamine with HPLC and fluorescence detection in whole blood, serum, vitreous humor, and urine.
    Clauwaert KM; Van Bocxlaer JF; De Letter EA; Van Calenbergh S; Lambert WE; De Leenheer AP
    Clin Chem; 2000 Dec; 46(12):1968-77. PubMed ID: 11106329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.